Earnings Labs
Longeveron Inc. logo

Longeveron Inc. (LGVN) Earnings Dates & History

NASDAQ·Healthcare·Biotechnology

$0.88

-1.77%

Mkt Cap $20.97M

EPS — Estimate vs Actual

Revenue — Estimate vs Actual

Quarterly History

Q1 2026

Mar 17, 2026

$110.33K$365.00K+230.82%-$0.42-$0.22+47.62%
Q4 2025

Nov 4, 2025

$110.33K$137.00K+24.17%-$0.26-$0.39-50.00%
Q3 2025

Aug 13, 2025

$444.00K$316.00K-28.83%-$0.35-$0.33+5.71%
Q2 2025

May 8, 2025

$592.67K$381.00K-35.71%-$0.34-$0.34+0.00%
Q1 2025

Feb 28, 2025

$578.66K$603.00K+4.21%-$0.36-$2.50-594.44%
Q4 2024

Nov 12, 2024

$395.50K$773.00K+95.45%-$0.53-$0.34+35.85%
Q3 2024

Aug 14, 2024

$500.00K$468.00K-6.40%-$1.03-$1.83-77.67%
Q2 2024

May 14, 2024

$60.00K$548.00K+813.33%-$2.01-$1.61+19.90%
Q1 2024

Feb 27, 2024

$210.00K$63.00K-70.00%-$2.10-$2.50-19.05%
Q4 2023

Nov 10, 2023

$400.00K$150.00K-62.50%-$2.40-$2.80-16.67%
Q3 2023

Aug 11, 2023

$400.00K$217.00K-45.75%-$2.60-$2.70-3.85%
Q2 2023

May 12, 2023

$300.00K$279.00K-7.00%-$1.90-$2.20-15.79%
Q1 2023

Mar 10, 2023

$400.00K$121.00K-69.75%-$1.00-$2.10-110.00%
Q4 2022

Nov 14, 2022

$200.00K$265.00K+32.50%-$2.00-$2.50-25.00%
Q3 2022

Aug 12, 2022

$200.00K$466.00K+133.00%-$2.30-$2.70-17.39%
Q2 2022

May 13, 2022

$250.00K$370.00K+48.00%-$2.10-$1.70+19.05%
Q1 2022

Mar 11, 2022

$265.00K$209.00K-21.13%-$2.50-$2.00+20.00%
Q4 2021

Nov 12, 2021

$232.00K-$2.50
Q3 2021

Aug 13, 2021

$489.00K-$2.60
Q2 2021

May 14, 2021

$400.00K$376.00K-6.00%-$0.44-$1.80-309.09%
Q1 2021

Mar 30, 2021

$1.18M-$0.79
Q3 2020

Sep 30, 2020

$1.86M-$0.59
Q2 2020

Jun 30, 2020

$876.00K-$0.76
Q1 2020

Mar 31, 2020

$1.71M-$0.13
Q4 2019

Dec 31, 2019

$1.84M-$0.30